Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023725 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
A Phase 1 study of Sarcoma, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Study locations
NCT00023725 is a Phase 1 study of Sarcoma that has completed, run by Radiation Therapy Oncology Group. The trial reports 20 study locations across 3 states.
The verdict
NCT00023725, a Phase 1 study of Sarcoma, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20
- Study locations
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as SU5416 may stop the growth of cancer by stopping blood flow to the tumor. It is not yet known if radiation therapy is more effective with or without SU5416 in treating soft tissue sarcoma. PURPOSE: Phase I/II trial to compare the effectiveness of radiation therapy with or without SU5416 in treating patients who have stage IB or stage IIA soft tissue sarcoma.
Conditions Studied
Interventions
- PROCEDURE conventional surgery
- RADIATION radiation therapy
- DRUG semaxanib
Study Locations (20)
California
- Mount Diablo Medical Center - Concord
- Cancer Center and Beckman Research Institute, City of Hope - Duarte
- California Cancer Center - Fresno
- Saint Agnes Cancer Center - Fresno
- Sutter Health West Cancer Research Group - Greenbrae
- Loma Linda University Medical Center - Loma Linda
- Veterans Affairs Medical Center - Long Beach - Long Beach
- USC/Norris Comprehensive Cancer Center and Hospital - Los Angeles
- Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
- CCOP - Bay Area Tumor Institute - Oakland
- Huntington Cancer Center - Pasadena
- Cancer Care Center - Pomona
- Radiation Oncology Center - Sacramento - Sacramento
Alabama
- University of Alabama at Birmingham Comprehensive Cancer Center - Birmingham
- Huntsville Hospital System - Huntsville
- Comprehensive Cancer Institute of Huntsville - Huntsville
- MBCCOP - Gulf Coast - Mobile
- Alabama Oncology, LLC - Montgomery
- Radiation Oncology Associates of West Alabama - Tuscallosa
Arizona
- Foundation for Cancer Research and Education - Phoenix
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-08 |
| Est. Completion | 2003-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00023725
The ClinicalTrials.gov registry entry for NCT00023725 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 3 interventions - of which conventional surgery is the first listed.
NCT00023725 reports 20 study locations spanning 3 distinct geographic areas - top geographies include California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00023725 about?
NCT00023725 is a clinical study titled "Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as SU5416 may stop the growth of cancer by stopping blood flow to the tumor. It is not yet known if radiation therapy is more effective with or without SU5416 in treating soft tissue sarcoma. PURPOSE: Phase I/II ...
What is the current status of trial NCT00023725?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-08. Estimated completion is 2003-10.
What conditions does trial NCT00023725 study?
This clinical trial studies the following conditions: Sarcoma.
What interventions are being tested in trial NCT00023725?
The interventions under investigation include: conventional surgery (PROCEDURE), radiation therapy (RADIATION), semaxanib (DRUG).
Who is sponsoring clinical trial NCT00023725?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00023725 being conducted?
This trial has 20 study locations across Alabama, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Palbociclib and Pembrolizumab in Sarcoma
RECRUITING · Phase 1
-
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RECRUITING · Phase 1
-
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
RECRUITING · Phase 1
-
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
RECRUITING · Phase 1
-
A Study of MGC026 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.